(1)
In Vitro Cytotoxicity Analysis on Patient-Derived PBMCs to Predict 6-Mercaptopurine Therapy Response in Children With Acute Lymphoblastic Leukemia. IJBB 2024, 61 (6), 371-379. https://doi.org/10.56042/ijbb.v61i6.9285.